DAFTAR PUSTAKA

MATA KULIAH :

BIOFARMASETIKA

Disusun oleh PJMK :

M.M. Farida Lanawati Darsono, S.Si.,M.Sc

Semester GASAL
Tahun Akademik : 2022-2023

Universitas Katolik Widya Mandala Surabaya

Fakultas Farmasi

BU FARIDA_UKWMS 1
References
◼ Banakar, U.V., 1992. Pharmaceutical Dissolution Testing 2. pp. 1-3, 20-21, 192, Marcel
Dekker Inc., New York.
◼ Dressman J. 2007. Dissolution, Pharmaceutical Product Interchangeability and
Biopharmaceutics Classification, Why do Dissolution Testing?, Johann Wolfgang Goethe
University, Frankfurt am Main, Germany, WHO Programme, June 2007
◼ J.Dressman & J. Krämer Pharmaceutical Dissolution Testing“,, published by Taylor and
Francis
◼ General Chapter on Dissolution Testing (United States Pharmacopeia)
◼ Khan, K.A., 1975. The Concept of Dissolution, Efficiency, J. Pharm. Pharmac, 27, pp.48-49.
◼ Langenbucher, F., 1972. Linierization of Dissolution Rate Curve by Weibull Distribution, J.
Pharm. Pharmac, 24, pp. 972 – 981.
◼ Leeson, L.J. and Cartensen, J.T., 1974. Dissolution Technology, pp. 3-22, The Ind. Pharm.
Tech. Section of The Acad. Of Pharm. Sciences, Washington.
◼ Roy Hanson & Vivian Gray., 2005. Handbook of Dissolution Testing 3. Auflage“ Published
by Dissolution Technologies
◼ Sanaa A. El- Gizawy, Biopharmaceutics Classification System (BCS)
◼ Siregar, 1992. Validasi di Industri Farmasi, Institut Teknologi Bandung, Bandung, hal.38.
◼ Seng, Y.E., 2006. Delayed Drug Delivery Tecnologies: Background and New Systems, pp. 1-
10, Modified-Released Forum, Colorcon Inc.
◼ Shargel, L. and Yu, A.B.C., 1985. Biofarmasetika dan Farmakokinetika Terapan (edisi
kedua). Universitas Indonesia, Jakarta.
◼ Shargel, L., Pong, S.W. and Yu, A.B.C., 2005. Applied Biopharmaceutics and
Pharmacokinetics. 5th ed, pp. 8, 96-97, 115, Prentice-Hall International Inc., New York.
◼ Swarbick, J. and Boylan, J.C., 2002. Encyclopedia of Pharmaceutical Technology, 2nd
edition, Volume 1, pp. 156-170, Marcel Dekker, New York.
◼ Wagner, J.C., 1971. Biopharmaceutic and Relevant Pharmacokinetics, 1st ed, pp. 115-120,
Drug Intelligence Publishers, Illionis.
◼ Patrick J. Marroum Ph.D., Development, Evaluationand Applications of In Vivo In Vitro
Correlations, Office of New Drug Quality Assessment Food and Drug Administration
◼ Lawrence X. Yu, Ph. D., Factors Impacting Drug Dissolution and Absorption: Current State
of Science, Director for Science Office of Generic Drugs Food and Drug Administration,
Advisory Committee for Pharmaceutical Science May 3, 2005
◼ Dan laman-laman yang di diskusi kan langsung saat daring

BU FARIDA_UKWMS 2